INTERNATIONAL PATENT: CHIESI FARMACEUTICI S.P.A. FILES APPLICATION FOR "PHARMACEUTICAL DOSAGE FORMS FOR DEFERIPRONE AND DEFERASIROX COMBINED THERAPY"

GENEVA, Dec. 1 -- CHIESI FARMACEUTICI S.P.A. (Via Palermo 26/A43122 Parma) filed a patent application (PCT/EP2025/063656) for "PHARMACEUTICAL DOSAGE FORMS FOR DEFERIPRONE AND DEFERASIROX COMBINED THERAPY" on May 19, 2025. With publication no. WO/2025/242589, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PERTILE, Marisa (c/o Chiesi Farmaceutici S.p.a.Via Palermo 26/A43122 Parma), LUZZI, Roberta (c/o Chiesi Farmaceutici S.p.A.Via Palermo 26/A43122 Parma)

Abstract: The invention relates to a pharmaceutical dosage form fil...